Showing 1 - 9 of 9
This paper uses efficiency wage theory and the existence of community based sharing to hypothesize that labor markets in developing countries have multiple equilibria--the same economy can be stuck at different levels of unemployment with different levels of wages. The result is constrained to...
Persistent link: https://www.econbiz.de/10005553649
This paper uses efficiency wage theory and the existence of community-based sharing to hypothesize that labor markets in developing countries have multiple equilibria – the same economy can be stuck at different levels of unemployment with different levels of wages. The model is meant for...
Persistent link: https://www.econbiz.de/10005763563
This paper uses efficiency wage theory and the existence of community-based sharing to hypothesize that labor markets in developing countries have multiple equilibria—the same economy can be stuck at different levels of unemployment with different levels of wages. The model is meant for...
Persistent link: https://www.econbiz.de/10004995175
The resource-based view of the firm suggests that direct control over unique assets can form the basis of sustained competitive advantage. In contrast, the papers presented in this Special Issue examine the payoffs to cross-boundary resource management. These papers demonstrate the potency of...
Persistent link: https://www.econbiz.de/10005200281
Developing nations are challenged to strike a balance between their patent obligations as members of the World Trade Organisation (WTO) and their drug pricing strategies. The Brazilian approach to pharmaceutical price negotiations has been strikingly effective. Describing the context of the...
Persistent link: https://www.econbiz.de/10005202494
Although pharmaceutical counterfeiting incidents can be traced back thousands of years, it has been downplayed and even dismissed by pharmaceutical manufacturers in the past. That has changed. Pharmaceutical firms are newly dedicated to eradicate counterfeits globally and spending more money on...
Persistent link: https://www.econbiz.de/10005443224
Persistent link: https://www.econbiz.de/10005412117
The debate over access to medicines has principally centered on pharmaceutical patents and prohibitively high drug prices. Although a less recognized problem, counterfeit pharmaceuticals are certainly a more insidious barrier to access. Pharmaceutical counterfeiting is an invisible threat, not...
Persistent link: https://www.econbiz.de/10005694750
Persistent link: https://www.econbiz.de/10011033925